tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Aurinia Pharmaceuticals (AUPH) Ownership - Who Owns Aurinia Pharmaceuticals?

1,879 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 07, 2024
Peter Greenleaf
Ceo,director
Sold$711094
Mar 07, 2024Sold$194942
Mar 07, 2024
Matthew Maxwell Donley
Evp, Ops & Strategy
Sold$224064
Mar 07, 2024Sold$323372

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
30,516,000Insider21.10%155,326,440
12,800,039Insider8.85%65,152,199
10,618,712Insider7.34%54,049,244
9,854,799Insider6.81%50,160,927
8,888,888Insider6.15%45,244,440
5,872,518Institution4.06%29,891,117
1,250,000Insider0.86%6,362,500
1,250,000Insider0.86%6,362,500
1,134,995Insider0.78%5,777,125
1,126,915Institution0.78%5,735,997

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,194,134Institution2.21%16,258,142
1,146,782Institution0.79%5,837,120
943,954Institution0.65%4,804,726
504,038Institution0.35%2,525,230
463,353Institution0.32%2,321,399
119,931Institution0.08%600,854
101,215Institution0.07%515,184
75,844Institution0.05%386,046
75,228Institution0.05%375,388
67,173Institution0.05%341,911

FAQ

Who Owns Aurinia Pharmaceuticals (AUPH)?
Currently, no data Available
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?
Currently, no data Available
What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?
3Sbio Inc. owns the most shares of Aurinia Pharmaceuticals (AUPH).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis